Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Wockhardt

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Wockhardt's 2013 sales performance.

India denies Vertex patent on cystic fibrosis drug Orkambi

India denies Vertex patent on cystic fibrosis drug Orkambi

The patent was opposed by the Indian Pharmaceutical Alliance (IPA), a trade organisation representing India's larger pharmaceutical companies, including Cipla, Dr Reddy's Labs, Lupin, Nicholas Piramal, Ranbaxy and Wockhardt.

Opportunities in the medical devices sector in India

Opportunities in the medical devices sector in India Leading private hospitals that are currently controlling the country's healthcare sector include Apollo Hospitals Enterprise, Fortis Healthcare, Wockhardt Hospitals, Max Hospitals, Aravind Eye Hospitals and Manipal Hospitals, among others. .

Lilly wins Cymbalta exclusivity

Lilly filed the suit in 2008 after Wockhardt submitted an abbreviated new drug application with the US Food and Drug Administration (FDA) seeking approval of its generic Cymbalta product. ... Wockhardt last month and has now issued a new order requiring

Takeda settles Actos patent suits

The lawsuits were filed in response to abbreviated new drug applications (ANDA) submitted to the FDA by Mylan, Watson, Ranbaxy, Sandoz, Teva, Alphapharm, Torrent, Dr Reddy's Laboratories, Wockhardt, Synthon, and ... FDA. Takeda's settlements with

Slim pickings

Metoprolol . (Wockhardt). Hypertension, angina. US. N-acetyl-s-farnsylcysteine. Arazine (Rohto Pharmaceutical). Inflammation . Japan.

1 2 3 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Six Degrees Medical Consulting

For over a decade, our medical communication services have helped pharmaceutical companies optimize their brand, disease and corporate objectives. Building...

Latest intelligence

Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....

Infographics